The application of genomic and proteomic technologies in predictive, preventive and personalized medicine

Vascular Pharmacology

Volumn 45, Issue 5, 2006, Pages 258-267

  Collins, C D ^a   Purohit, S ^a   Podolsky, R H ^a   Zhao, H S ^a   Schatz, D ^b   Eckenrode, S E ^a   Yang, P ^a   Hopkins, D ^a   Muir, A ^a   Hoffman, M ^c   McIndoe, R A ^a   Rewers, M ^c   She, J X ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Biomarkers; Gene expression profiling; Proteomics; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; BRAIN PROTEIN; BRAIN PROTEIN 13; CALCIUM BINDING PROTEIN; CD74 ANTIGEN; COLONY STIMULATING FACTOR RECEPTOR; DEFENSIN; FERRITIN; GRANULYSIN; GRANZYME B; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; L SELECTIN; LAMININ RECEPTOR; LEUKOCYTE ANTIGEN; PEROXIREDOXIN; PROTEASOME; PROTEIN SUBUNIT; S100 CALCIUM BINDING PROTEIN A8; S100 CALCIUM BINDING PROTEIN A9; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; THYMOSIN BETA10; THYMOSIN BETA4; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOINFORMATICS; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

EID: 33751099342     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.08.003     Document Type: Article

References (82)

1. Agrawal A. CRP after 2004. Mol. Immunol. 42 (2005) 927-930
2. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson Jr. J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., and Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
3. Aslan M., and Ozben T. Reactive oxygen and nitrogen species in Alzheimer's disease. Curr. Alzheimer Res. 1 (2004) 111-119
4. Atkinson M.A. ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?. Diabetes 54 (2005) 1253-1263
5. Austen B.M., Frears E.R., and Davies H. The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells. J. Pept. Sci. 6 (2000) 459-469
6. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., and Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. 100 (2003) 2610-2615
7. Berchuck A., Iversen E.S., Lancaster J.M., Pittman J., Luo J., Lee P., Murphy S., Dressman H.K., Febbo P.G., West M., Nevins J.R., and Marks J.R. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin. Cancer Res. 11 (2005) 3686-3696
8. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., and Gale E.A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46 (1997) 1701-1710
9. Bishop C.M. Neural Networks for Pattern Recognition, Oxford (1995)
10. Bossy-Wetzel E., Schwarzenbacher R., and Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 10 Suppl: S2-9 (2004) S2-S9
11. Breiman L. Bagging predictors. Mach. Learn. 24 (1996) 123-140
12. Breiman L., 1999. Random Forests- Random Features. Technical Report. 567.
13. Breiman L. Arcing classifiers. Annu. Stat. 26 (2004) 801-824
14. Breiman L. Classification and Regression Trees (2004), CA, Belmont
15. Carmichael S.K., Johnson S.B., Baughcum A., North K., Hopkins D., Dukes M.G., She J.X., and Schatz D.A. Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet. Med. 5 (2003) 77-83
16. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
17. Collier J., and Bassendine M. How to respond to abnormal liver function tests. Clin. Med. 2 (2002) 406-409
18. Concannon P., Gogolin-Ewens K.J., Hinds D.A., Wapelhorst B., Morrison V.A., Stirling B., Mitra M., Farmer J., Williams S.R., Cox N.J., Bell G.I., Risch N., and Spielman R.S. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat. Genet. 19 (1998) 292-296
19. Conigrave K.M., Davies P., Haber P., and Whitfield J.B. Traditional markers of excessive alcohol use. Addiction 98 Suppl. 2 (2003) 31-43
20. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C., Jenkins S.C., and Palmer S.M. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371 (1994) 130-136
21. Dorner T., Egerer K., Feist E., and Burmester G.R. Rheumatoid factor revisited. Curr. Opin. Rheumatol. 16 (2004) 246-253
22. Dudoit S., Fridlyand J., and Speed T.P. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc. 97 (2002) 77-87
23. Duffy M.J. CA 15-3 and related mucins as circulating markers in breast cancer. Ann. Clin. Biochem. 36 (1999) 579-586
24. Eckenrode S.E., Ruan Q., Yang P., Zheng W., McIndoe R.A., and She J.X. Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice. Diabetes 53 (2004) 366-375
25. Eisenbarth G.S., Gianani R., Yu L., Pietropaolo M., Verge C.F., Chase H.P., Redondo M.J., Colman P., Harrison L., and Jackson R. Dual-parameter model for prediction of type I diabetes mellitus. Proc. Assoc. Am. Physicians 110 (1998) 126-135
26. Fels L.M., Buschmann T., Meuer J., Reymond M.A., Lamer S., Rocken C., and Ebert M.P. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer. Dig. Dis. 21 (2003) 292-298
27. Fournier T., Medjoubi N., and Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 1482 (2000) 157-171
28. Frederick K., Beck M.D., and Rosenthal M.D. Prealbumin: A marker for nutritional evaluation. Am. Fam. Physician 65 (2002) 1575-1578
29. Futcher B., Latter G.I., Monardo P., McLaughlin C.S., and Garrels J.I. A sampling of the yeast proteome. Mol. Cell. Biol. 19 (1999) 7357-7368
30. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., and Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
31. Guo D., Li M., Zhang Y., Yang P., Eckenrode S., Hopkins D., Zheng W., Purohit S., Podolsky R.H., Muir A., Wang J., Dong Z., Brusko T., Atkinson M., Pozzilli P., Zeidler A., Raffel L.J., Jacob C.O., Park Y., Serrano-Rios M., Larrad M.T., Zhang Z., Garchon H.J., Bach J.F., Rotter J.I., She J.X., and Wang C.Y. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat. Genet. 36 (2004) 837-841
32. Hashimoto L., Habita C., Beressi J.P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J.I., Djoulah S., and James M.R. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371 (1994) 161-164
33. Hirji K.F., Mehta C.R., and Patel N.R. Computing distributions for exact logistic regression. J. Am. Stat. Assoc. 82 (1987) 1110-1117
34. Hodgetts A., Bosse J.T., Kroll J.S., and Langford P.R. Analysis of differential protein expression in Actinobacillus pleuropneumoniae by Surface Enhanced Laser Desorption Ionisation-ProteinChip (SELDI) technology. Vet. Microbiol. 19 (2004) 215-225
35. Huang E., Cheng S.H., Dressman H., Pittman J., Tsou M.H., Horng C.F., Bild A., Iversen E.S., Liao M., Chen C.M., West M., Nevins J.R., and Huang A.T. Gene expression predictors of breast cancer outcomes. Lancet 361 (2003) 1590-1596
36. Huang E., West M., and Nevins J.R. Gene expression profiling for prediction of clinical characteristics of breast cancer. Recent Prog. Horm. Res. 58 (2003) 55-73
37. Jarvis J.N., Dozmorov I., Jiang K., Frank M.B., Szodoray P., Alex P., and Centola M. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res. Ther. 6 (2004) R15-R32
38. Kanikowska D., Grzymislawski M., and Wiktorowicz K. Seasonal rhythms of "acute phase proteins" in humans. Chronobiol. Int. 22 (2005) 591-596
39. Kleinberg E.M. Stochastic discrimination. Ann. Math. Artif. Intell. (1990) 207-239
40. Kleinberg E.M. An overtaining-resistant stochastic modeling method for pattern recognition. Ann. Stat. 24 (1996) 2319-2349
41. Knip M. Can we predict type 1 diabetes in the general population?. Diabetes Care 25 (2002) 623-625
42. Kretowski A., Gillespie K.M., Bingley P.J., and Kinalska I. Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity?. Immunology 99 (2000) 320-325
43. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hamalainen A.M., Korhonen S., Kimpimaki T., Sjoroos M., Ilonen J., Knip M., and Simell O. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44 (2001) 290-297
44. LaGasse J.M., Brantley M.S., Leech N.J., Rowe R.E., Monks S., Palmer J.P., Nepom G.T., McCulloch D.K., and Hagopian W.A. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 25 (2002) 505-511
45. Lancashire L., Schmid O., Shah H., and Ball G. Classification of bacterial species from proteomic data using combinatorial approaches incorporating artificial neural networks, cluster analysis and principal components analysis. Bioinformatics 21 (2005) 2191-2199
46. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la B.M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., and Chen Y.J. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
47. Lane C.S. Mass spectrometry-based proteomics in the life sciences. Cell. Mol. Life Sci. 62 (2005) 848-869
48. Li L., Darden T.A., Weinberg C.R., Levine A.J., and Pedersen L.G. Gene assessment and sample classification for gene expression data using a genetic algorithm/k-nearest neighbor method. Comb. Chem. High Throughput Screen. 4 (2001) 727-739
49. Li L., Weinberg C.R., Darden T.A., and Pedersen L.G. Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics 17 (2001) 1131-1142
50. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
51. Lomas D.A. Molecular mousetraps, alpha1-antitrypsin deficiency and the serpinopathies. Clin. Med. 5 (2005) 249-257
52. Luo D.F., Buzzetti R., Rotter J.I., Maclaren N.K., Raffel L.J., Nistico L., Giovannini C., Pozzilli P., Thomson G., and She J.X. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum. Mol. Genet. 5 (1996) 693-698
53. Masaki Y., and Sugai S. Lymphoproliferative disorders in Sjogren's syndrome. Autoimmun. Rev. 3 (2004) 175-182
54. Mysliwiec J., Kretowski A., Szelachowska M., Topolska J., Mikita A., and Kinalska I. Serum L-selectin and ICAM-1 in patients with Graves' ophthalmopathy during treatment with corticosteroids. Immunol. Lett. 78 (2001) 123-126
55. Nejentsev S., Sjoroos M., Soukka T., Knip M., Simell O., Lovgren T., and Ilonen J. Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet. Med. 16 (1999) 985-992
56. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., and Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59 (1996) 1134-1148
57. Notkins A.L. Type 1 diabetes as a model for autoantibodies as predictors of autoimmune diseases. Autoimmun. Rev. 3 Suppl. 1 (2004) S7-S9
58. Pandey A., and Mann M. Proteomics to study genes and genomes. Nature 405 (2000) 837-846
59. Paweletz C.P., Trock B., Pennanen M., Tsangaris T., Magnant C., Liotta L.A., and Petricoin III E.F. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers 17 (2001) 301-307
60. Pender M.P. Neurology. 4: Multiple sclerosis. Med. J. Aust. 172 (2000) 556-562
61. Poole A.R., Nelson F., Dahlberg L., Tchetina E., Kobayashi M., Yasuda T., Laverty S., Squires G., Kojima T., Wu W., and Billinghurst R.C. Proteolysis of the collagen fibril in osteoarthritis. Biochem. Soc. Symp. (2003) 115-123
62. Qu Y., Adam B.L., Yasui Y., Ward M.D., Cazares L.H., Schellhammer P.F., Feng Z., Semmes O.J., and Wright Jr. G.L. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48 (2002) 1835-1843
63. Ramanathan M., Weinstock-Guttman B., Nguyen L.T., Badgett D., Miller C., Patrick K., Brownscheidle C., and Jacobs L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116 (2001) 213-219
64. Rapkiewicz A.V., Espina V., Petricoin III E.F., and Liotta L.A. Biomarkers of ovarian tumours. Eur. J. Cancer. 40 (2004) 2604-2612
65. Regnier F.E., Riggs L., Zhang R., Xiong L., Liu P., Chakraborty A., Seeley E., Sioma C., and Thompson R.A. Comparative proteomics based on stable isotope labeling and affinity selection. J. Mass Spectrom. 37 (2002) 133-145
66. Rewers M., Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., McDuffie Jr. R.S., Hamman R.F., Klingensmith G., Eisenbarth G.S., and Erlich H.A. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39 (1996) 807-812
67. Robinson W.H., Steinman L., and Utz P.J. Proteomics technologies for the study of autoimmune disease. Arthritis Rheum. 46 (2002) 885-893
68. Rosai J. Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori 89 (2003) 517-519
69. Rulli M., and Simell O. Avidity of islet cell autoantibodies in non-diabetic children and children with insulin-dependent diabetes. Autoimmunity 31 (1999) 187-193
70. Rus V., Atamas S.P., Shustova V., Luzina I.G., Selaru F., Magder L.S., and Via C.S. Expression of cytokine-and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin. Immunol. 102 (2002) 283-290
71. Sadrzadeh S.M., and Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 121 Suppl:S97-104 (2004) S97-S104
72. Shitrit D., Zingerman B., Shitrit A.B., Shlomi D., and Kramer M.R. Diagnostic Value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 Assays in Pleural Effusions: Analysis of 116 Cases and Review of the Literature. Oncologist 10 (2005) 501-507
73. Teunissen C.E., de Vente J., Steinbusch H.W., and De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol. Aging 23 (2002) 485-508
74. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. 93 (1996) 12142-12149
75. Veijola R., Reijonen H., Vahasalo P., Sabbah E., Kulmala P., Ilonen J., Akerblom H.K., and Knip M. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. J. Clin. Invest. 98 (1996) 2489-2495
76. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R., Chaturvedi K., Deng Z., Di F., Dunn V., Eilbeck P., Evangelista K., Gabrielian C., Gan W., Ge W., Gong F., Gu Z., Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D., McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M., Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C., Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B., Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., and Nodell M. The sequence of the human genome. Science 291 (2001) 1304-1351
77. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
78. Wang H., and Hanash S. Intact-protein based sample preparation strategies for proteome analysis in combination with mass spectrometry. Mass Spectrom. Rev. 24 (2005) 413-426
79. Weetman A.P. Autoimmune thyroid disease. Autoimmunity 37 (2004) 337-340
80. Yan W., and Chen S.S. Mass spectrometry-based quantitative proteomic profiling. Brief. Funct. Genomic. Proteomic. 4 (2005) 27-38
81. Yang Q., Khoury M.J., Botto L., Friedman J.M., and Flanders W.D. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am. J. Hum. Genet. 72 (2003) 636-649
82. Ziegler R., and Eisenbarth G.S. Multiple target antigens in pre-type I diabetes: implications for prediction. Horm. Res. 33 (1990) 144-150